Pharma
NewsBY
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign, making lobbying a challenge in 2025.
NewsBY
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign, making lobbying a challenge in 2025.
- As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country
- As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country
- As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country
- The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister
- The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister
- The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister
- Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works
- Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works
- Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works
- Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
- Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
- Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
